Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
Jay H. Traverse(University of Minnesota), Timothy D. Henry(Abbott Northwestern Hospital), Douglas Vaughn(Vanderbilt University), Stephen G. Ellis(Cleveland Foundation), Carl J. Pepine(University of Florida), James T. Willerson, David Zhao(Vanderbilt University), Linda B. Piller(The University of Texas Health Science Center at Houston), Marc S. Penn(Cleveland Foundation), Barry J. Byrne(University of Florida), Emerson C. Perin, Adrian P. Gee(Baylor School), Antonis K. Hatzopoulos(Vanderbilt University), David H. McKenna(University of Minnesota), John R. Forder(University of Florida), Doris A. Taylor(University of Minnesota), Christopher R. Cogle(University of Florida), Rachel Olson(Minneapolis Heart Institute Foundation), Beth Jorgenson(Vanderbilt University), Shelly L. Sayre(The University of Texas Health Science Center at Houston), Rachel W. Vojvodic, David J. Gordon, Sonia I. Skarlatos, Lemuel A. Moye', Robert D. Simari
Cited by 77
Abstract
Related Papers
No related papers found
Powered by citation graph analysis